The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 21, 2025

Filed:

Mar. 25, 2024
Applicant:

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Matthew Bacchetta, Tenafly, NJ (US);

Scott Chicotka, New York, NY (US);

Kenmond Fung, New York, NY (US);

Brandon Guenthart, New York, NY (US);

John O'Neill, New York, NY (US);

Gordana Vunjak-Novakovic, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 1/00 (2006.01); A01N 1/10 (2025.01); A01N 1/122 (2025.01); A01N 1/143 (2025.01); A61J 1/00 (2023.01); A61M 1/16 (2006.01); C12M 1/00 (2006.01); C12M 1/34 (2006.01); A01N 1/16 (2025.01); A61M 1/36 (2006.01); A61M 1/38 (2006.01);
U.S. Cl.
CPC ...
A01N 1/122 (2025.01); A01N 1/10 (2025.01); A01N 1/143 (2025.01); A61J 1/00 (2013.01); A61M 1/16 (2013.01); C12M 29/12 (2013.01); C12M 29/14 (2013.01); C12M 41/16 (2013.01); A01N 1/16 (2025.01); A61M 1/3621 (2013.01); A61M 1/38 (2013.01); A61M 2210/1039 (2013.01);
Abstract

Described are systems, methods, and devices relating to normothermic extracorporeal support of an organ, tissue, or bioengineered graft comprising cross-circulation (XC) perfusion for prolonged periods (days to weeks) via an XC perfusion circuit in connection with an extracorporeal host (e.g., animal, patient, organ transplant recipient) are disclosed. The XC perfusion circuit comprises auto-regulation of blood flow based on the trans-organ blood pressure difference between arterial and venous pressure. Recipient support enabled 36 h of normothermic perfusion that maintained healthy lungs with no significant changes in physiologic parameters and allowed for the recovery of injured lungs. Extended support enabled multiscale therapeutic interventions in all extracorporeal lungs. Lungs exceeded transplantation criteria.


Find Patent Forward Citations

Loading…